A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.
Identifieur interne : 001866 ( PubMed/Corpus ); précédent : 001865; suivant : 001867A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.
Auteurs : David W. Chang ; Hiroo Suami ; Roman SkorackiSource :
- Plastic and reconstructive surgery [ 1529-4242 ] ; 2013.
English descriptors
- KwdEn :
- Anastomosis, Surgical, Coloring Agents, Extremities (diagnostic imaging), Extremities (surgery), Humans, Indocyanine Green, Lymphatic Vessels (diagnostic imaging), Lymphatic Vessels (surgery), Lymphedema (diagnostic imaging), Lymphedema (surgery), Lymphography, Middle Aged, Neoplasms (therapy), Prospective Studies, Veins (surgery).
- MESH :
- chemical : Coloring Agents, Indocyanine Green.
- diagnostic imaging : Extremities, Lymphatic Vessels, Lymphedema.
- surgery : Extremities, Lymphatic Vessels, Lymphedema, Veins.
- therapy : Neoplasms.
- Anastomosis, Surgical, Humans, Lymphography, Middle Aged, Prospective Studies.
Abstract
The authors prospectively evaluated the efficacy of lymphovenous bypass in patients with lymphedema secondary to cancer treatment.
DOI: 10.1097/PRS.0b013e3182a4d626
PubMed: 24165613
Links to Exploration step
pubmed:24165613Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.</title><author><name sortKey="Chang, David W" sort="Chang, David W" uniqKey="Chang D" first="David W" last="Chang">David W. Chang</name><affiliation><nlm:affiliation>Houston, Texas From the Department of Plastic Surgery, The University of Texas M. D. Anderson Cancer Center.</nlm:affiliation></affiliation></author><author><name sortKey="Suami, Hiroo" sort="Suami, Hiroo" uniqKey="Suami H" first="Hiroo" last="Suami">Hiroo Suami</name></author><author><name sortKey="Skoracki, Roman" sort="Skoracki, Roman" uniqKey="Skoracki R" first="Roman" last="Skoracki">Roman Skoracki</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24165613</idno><idno type="pmid">24165613</idno><idno type="doi">10.1097/PRS.0b013e3182a4d626</idno><idno type="wicri:Area/PubMed/Corpus">001866</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001866</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.</title><author><name sortKey="Chang, David W" sort="Chang, David W" uniqKey="Chang D" first="David W" last="Chang">David W. Chang</name><affiliation><nlm:affiliation>Houston, Texas From the Department of Plastic Surgery, The University of Texas M. D. Anderson Cancer Center.</nlm:affiliation></affiliation></author><author><name sortKey="Suami, Hiroo" sort="Suami, Hiroo" uniqKey="Suami H" first="Hiroo" last="Suami">Hiroo Suami</name></author><author><name sortKey="Skoracki, Roman" sort="Skoracki, Roman" uniqKey="Skoracki R" first="Roman" last="Skoracki">Roman Skoracki</name></author></analytic><series><title level="j">Plastic and reconstructive surgery</title><idno type="eISSN">1529-4242</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anastomosis, Surgical</term><term>Coloring Agents</term><term>Extremities (diagnostic imaging)</term><term>Extremities (surgery)</term><term>Humans</term><term>Indocyanine Green</term><term>Lymphatic Vessels (diagnostic imaging)</term><term>Lymphatic Vessels (surgery)</term><term>Lymphedema (diagnostic imaging)</term><term>Lymphedema (surgery)</term><term>Lymphography</term><term>Middle Aged</term><term>Neoplasms (therapy)</term><term>Prospective Studies</term><term>Veins (surgery)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Coloring Agents</term><term>Indocyanine Green</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Extremities</term><term>Lymphatic Vessels</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Extremities</term><term>Lymphatic Vessels</term><term>Lymphedema</term><term>Veins</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Anastomosis, Surgical</term><term>Humans</term><term>Lymphography</term><term>Middle Aged</term><term>Prospective Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The authors prospectively evaluated the efficacy of lymphovenous bypass in patients with lymphedema secondary to cancer treatment.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24165613</PMID><DateCreated><Year>2013</Year><Month>10</Month><Day>29</Day></DateCreated><DateCompleted><Year>2014</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-4242</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Plastic and reconstructive surgery</Title><ISOAbbreviation>Plast. Reconstr. Surg.</ISOAbbreviation></Journal><ArticleTitle>A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.</ArticleTitle><Pagination><MedlinePgn>1305-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PRS.0b013e3182a4d626</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The authors prospectively evaluated the efficacy of lymphovenous bypass in patients with lymphedema secondary to cancer treatment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The authors prospectively enrolled 100 consecutive patients with extremity lymphedema secondary to cancer treatment. Sixty-five patients underwent lymphovenous bypass with indocyanine green fluorescent lymphangiography. Evaluation included qualitative assessment and quantitative volumetric analysis before and 3, 6, and 12 months after bypass.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Lymphovenous bypass was performed in 89 upper extremities and 11 lower extremities. For upper extremity lymphedemas, the mean preoperative volume differential was 32 percent. Symptom improvement was reported by 96 percent of patients and quantitative improvement was noted by 74 percent. The overall mean volume differential reduction was 33 percent at 3 months, 36 percent at 6 months, and 42 percent at 12 months after surgery. The mean volume differential reductions at 3, 6, and 12 months after lymphovenous bypass in patients with stage 1 or 2 lymphedema (58, 52, and 61 percent, respectively) were significantly larger than those in the patients with stage 3 or 4 lymphedema (12, 16, and 17 percent, respectively). Eleven bypasses were performed in seven patients with lower extremity lymphedema, with a mean preoperative volume differential of 38 percent. Only four (57 percent) of these patients reported symptom improvement; postoperative volume measurements were available for only two of these four.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Lymphovenous bypass can be effective in reducing lymphedema severity, particularly in patients with early-stage upper extremity lymphedema. Indocyanine green lymphangiography accurately identified functional lymphatic vessels and may have a role in objectively assessing lymphedema severity and patient selection.</AbstractText><AbstractText Label="CLINICAL QUESTION/LEVEL OF EVIDENCE" NlmCategory="METHODS">Therapeutic, IV.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Houston, Texas From the Department of Plastic Surgery, The University of Texas M. D. Anderson Cancer Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suami</LastName><ForeName>Hiroo</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Skoracki</LastName><ForeName>Roman</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA016672</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA016672</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Plast Reconstr Surg</MedlineTA><NlmUniqueID>1306050</NlmUniqueID><ISSNLinking>0032-1052</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>IX6J1063HV</RegistryNumber><NameOfSubstance UI="D007208">Indocyanine Green</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Plast Reconstr Surg. 2014 Jun;133(6):888e-889e</RefSource><PMID Version="1">24867752</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Plast Reconstr Surg. 2014 Jun;133(6):887e-888e</RefSource><PMID Version="1">24867751</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004396" MajorTopicYN="N">Coloring Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005121" MajorTopicYN="N">Extremities</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007208" MajorTopicYN="N">Indocyanine Green</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042601" MajorTopicYN="N">Lymphatic Vessels</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008220" MajorTopicYN="N">Lymphography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014680" MajorTopicYN="N">Veins</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24165613</ArticleId><ArticleId IdType="doi">10.1097/PRS.0b013e3182a4d626</ArticleId><ArticleId IdType="pii">00006534-201311000-00048</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001866 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001866 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24165613
|texte= A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24165613" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |